AVBP
ArriVent BioPharma, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
ArriVent BioPharma (AVBP) Stock: Buy, Sell, or Hold?
$13.51
+0.02 (+0.11%)
â˛
5d:
+0.11%
30d:
-16.07%
90d:
-54.98%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (95%)
Quality Score
53/100
Position
SLIGHTLY LOW
30-Day Fair Range
$13.15 â $24.26
Position: SLIGHTLY LOW
Forward P/E & Valuation
-3.4x
Next 12M consensus est.
Wall Street Target
$25.80
+91.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$12.00 / $16.42
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: AVBP is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When AVBP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: AVBP is currently trading at $13.51, which is considered slightly low relative to its 30-day fair value range of $13.15 to $24.26.
Technical Outlook: Technically, AVBP is in a strong downtrend. Immediate support is located at $12.00, while resistance sits at $16.42.
Market Sentiment: AVBP scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.80 (+91.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AVBP is in a strong downtrend. Immediate support is located at $12.00, while resistance sits at $16.42.
Market Sentiment: AVBP scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.80 (+91.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$13.15 -
$24.26
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$13.15 -
$24.26
Current vs Trading Range
SLIGHTLY LOW
Support Level
$12.00
Resistance Level
$16.42
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 91.0% below Wall St target ($25.80)
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.44
Wall Street Target
$25.80
(+91.0%)
Share AVBP Analysis
Share this live AVBP analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (AVBP)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 26, 2026
Daily AI digest
AI Retail Discussion Summary:
ArriVent reported initial encouraging Phase 1 results for ARR-217, a CDH17-targeting ADC, at ESMO Congress 2026. The data showed a 44.8% ORR at 6mg/kg dose in late-line CRC patients and a manageable safety profile.
Key Retail Themes:
Clinical trial results
CDH17-targeting ADC
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 3:01 AM ET
Data refreshes hourly during market hours. Next update: 4:01 AM
Data refreshes hourly during market hours. Next update: 4:01 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVBP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$689 | 56 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive AVBP Research Pages
